Generics and biosimilars are key to keeping medicines accessible & health systems sustainable. At @medicinesforEU Conference in Athens, I highlighted how #pharmareform, #CriticalMedicinesAct & #BiotechAct will strengthen affordability, supply resilience and 🇪🇺medicine security. https://t.co/cJW6Qhq6C3 #pharmareform #CriticalMedicinesAct #BiotechAct #EU
Patients across 🇪🇺 should have access to the medicines they need, when they need them. At tonight’s @Europarl_EN debate, I highlighted the tools we are putting in place - from the #CriticalMedicinesAct to the pharma reform & Biotech Act - to strengthen Europe’s resilience. https://t.co/G8pjUtPVBI #HealthCare #PharmaReform #EuropeResilience #EU
universal access to high-quality healthcare, combined with access to the best available innovation. The implementation of the #EHDS, pharma reform and the #CriticalMedicinesAct will be key to deliver this. #HealthcareForAll #InnovationInHealthcare #PharmaReform #Thetweetdoesnotmentionanyspecificcountries.Therefore #therearenocountrycodestoreturn.
